A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Condition:   Type 2 Diabetes MellitusInterventions:   Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Glipizide;   Drug: Placebo to glipizide;   Biological: InsulinSponsor:   Merck Sharp & Dohme Corp.Active, not recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials